Mangoceuticals (MGRX) Inventory Average (2023 - 2024)
Mangoceuticals' (MGRX) quarterly Inventory Average came in at -$2644.0 in Q4 2024, down 113.19% year-on-year from $20041.0 in Q1 2024, and down 119.42% quarter-over-quarter from $13616.0 in Q3 2024.
Mangoceuticals (MGRX) Inventory Average (2023 - 2024) Analysis & Trends
Mangoceuticals has disclosed Inventory Average across 2 years of filings, most recently posting -$2644.0 for Q4 2024.
- Inventory Average for Q4 2024 came in at -$2644.0, down 113.19% year-over-year; the trailing twelve-month figure through Dec 2024 was -$2644.0 (down 113.19% YoY), and the FY2024 annual result was $0.0, changed N/A from the prior year.
- Inventory Average came in at -$2644.0 for Q4 2024 at Mangoceuticals, down from $13616.0 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $22537.5 in Q3 2023 to a low of -$2644.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 687.67 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 14.90 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 54.91 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | - |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 100.05 Mn |
| 10 | Mangoceuticals | 5.25 Mn | 5.06 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2,644.00 |
| Sep 30, 2024 | 13,616.00 |
| Jun 30, 2024 | 14,235.50 |
| Mar 31, 2024 | 16,476.50 |
| Dec 31, 2023 | 20,041.00 |
| Sep 30, 2023 | 22,537.50 |